Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-07

Clinical Trial Update: Study on Human Mass Balance of SPH3127 Tablets [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating human mass balance of SPH3127 tablets for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPH3127

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Primary Mild and Moderate Hypertension | Phase 1, Phase 2 | Status: COMPLETED